Jason Lettmann, CHIEF EXECUTIVE OFFICER at ALX ONCOLOGY HOLDINGS INC (ALXO), bought 4,400 shares at $11.31 ($50K) on 2024-03-14, disclosed to the SEC on 2024-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALXO | BUY | 2025-09-18 | $176K | — | Filing → |
| ALXO | SELL | 2025-08-19 | $2K | — | Filing → |
| ALXO | SELL | 2025-02-21 | $2K | — | Filing → |